Incidence of gastro-intestinal anomalies and surgical outcome of fetuses diagnosed with echogenic bowel and bowel dilatation.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
11 2019
Historique:
received: 23 06 2019
revised: 18 08 2019
accepted: 19 08 2019
pubmed: 29 8 2019
medline: 10 7 2020
entrez: 29 8 2019
Statut: ppublish

Résumé

We aimed to evaluate the incidence of gastro-intestinal (GI) anomalies and surgical outcome in fetuses diagnosed with either echogenic bowel (EB) or EB plus bowel dilatation (BD) but no associated chromosomal, DNA and/or additional structural defects. A 10-year (2008-2018) retrospective review was performed on all fetuses diagnosed with EB and EB+BD (RES-18-0000-072Q). Results are reported as number of cases (%) and mean ±SD. Fisher's exact test, Mann-Whitney U test and logistic regression were used to identify differences between groups and predisposing factors for gastro-intestinal anomalies. We identified 41 fetuses with EB and 14 fetuses with EB+BD. Post-natal surgical intervention was required in no patient of the EB group and in 7/14 (50%) of the EB+BD group, p<0.001. The risk of having a GI anomaly was higher in the EB+BD group (RR 42.0 [2.5-691.6]; p=0.009). Advanced maternal age (p=0.04), ascites (p=0.006) and polyhydramnios (p=0.007) were associated with a higher incidence of GI pathology. In fetuses with no associated chromosomal, DNA and/or additional structural defects, the finding of EB+BD is associated with 50% incidence of GI anomalies at birth. Advanced maternal age, ascites and polyhydramnios are also associated with higher incidence of GI pathology at birth.

Sections du résumé

BACKGROUND
We aimed to evaluate the incidence of gastro-intestinal (GI) anomalies and surgical outcome in fetuses diagnosed with either echogenic bowel (EB) or EB plus bowel dilatation (BD) but no associated chromosomal, DNA and/or additional structural defects.
METHODS
A 10-year (2008-2018) retrospective review was performed on all fetuses diagnosed with EB and EB+BD (RES-18-0000-072Q). Results are reported as number of cases (%) and mean ±SD. Fisher's exact test, Mann-Whitney U test and logistic regression were used to identify differences between groups and predisposing factors for gastro-intestinal anomalies.
RESULTS
We identified 41 fetuses with EB and 14 fetuses with EB+BD. Post-natal surgical intervention was required in no patient of the EB group and in 7/14 (50%) of the EB+BD group, p<0.001. The risk of having a GI anomaly was higher in the EB+BD group (RR 42.0 [2.5-691.6]; p=0.009). Advanced maternal age (p=0.04), ascites (p=0.006) and polyhydramnios (p=0.007) were associated with a higher incidence of GI pathology.
CONCLUSIONS
In fetuses with no associated chromosomal, DNA and/or additional structural defects, the finding of EB+BD is associated with 50% incidence of GI anomalies at birth. Advanced maternal age, ascites and polyhydramnios are also associated with higher incidence of GI pathology at birth.

Identifiants

pubmed: 31461799
doi: 10.1002/pd.5552
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1115-1119

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Références

Dicke JM, Crane JP. Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management. Obstet Gynecol. 1992;80:778-782.
Goetzinger KR, Cahill AG, Macones GA, Odibo AO. Echogenic bowel on second-trimester ultrasonography: evaluating the risk of adverse pregnancy outcome. Obstet Gynecol. 2011;117(6):1341-1348.
Slotnick RN, Abuhamad AZ. Prognostic implications of fetal echogenic bowel. Lancet. 1996;347(8994):85-87.
Buiter HD, Holswilder-Olde Scholtenhuis MA, Bouman K, et al. Outcome of infants presenting with echogenic bowel in the second trimester of pregnancy. Arch Dis Child Fetal Neonatal Ed. 2013;98(3):F256-F259.
Simon-Bouy B, Satre V, Ferec C, et al. Hyperechogenic fetal bowel: a large French collaborative study of 682 cases. Am J Med Genet A. 2003;121A(3):209-213.
Berlin BM, Norton ME, Sugarman EA, et al. Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel. Obstet Gynecol. 1999;94:135-138.
Bromley B, Doubilet P, Frigoletto FD, et al. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis? Obstet Gynecol. 1994;83:647-651.
Jackson CR, Orford J, Minutillo C, Dickinson J. Dilated and echogenic fetal bowel and postnatal outcomes: a surgical perspective. Case series and literature review. Eur J Pediatr Surg. 2010;20(03):191-193.
Muller F, Dommergues M, Aubry MC, et al. Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome. Am J Obstet Gynecol. 1995;173(2):508-513.
Virgone C, D'Antonio F, Khalil A, Jonh R, Manzoli L, Giuliani S. Accuracy of prenatal ultrasound in detecting jejunal and ileal atresia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45(5):523-529.
Catania VD, Taddei A, Pellegrino M, et al. Hyperechogenic Bowel: Etiologies, Management, and Outcome according to Gestational Age at Diagnosis in 279 Consecutive Cases in a Single Center. Eur J Pediatr Surg. 2017;27:109-115.
Nyberg DA, Mack LA, Patten RM, Cyr DR. Fetal bowel. Normal sonographic findings. J Ultrasound Med. 1987;6(1):3-6.
Lince DM, Pretorius DH, Manco-Johnson ML, Manchester D, Clewell WH. The clinical significance of increased echogenicity in the fetal abdomen. AJR Am J Roentgenol. 1985;145(4):683-686.
Sepulveda W, Sebire NJ. Fetal echogenic bowel: a complex scenario. Ultrasound Obstet Gynecol. 2000;16(6):510-514.
Vincoff NS, Callen PW, Smith-Bindman R, Goldstein RB. Effect of ultrasound transducer frequency on the appearance of the fetal bowel. J Ultrasound Med. 1999;18(12):799-803.
Dalla Vecchia LK, Grosfeld JL, West KW, et al. Intestinal atresia and stenosis: a 25-year experience with 277 cases. Arch Surg. 1998;133:490-496.
Ionescu S, Andrei B, Oancea M, et al. Postnatal treatment in antenatally diagnosed meconium peritonitis. Chirurgia (Bucur). 2015;110:538-544.
Jo YS, Jang DG, Nam SY, Choi SK, Shin JC, Lee G. Antenatal sonographic features of ileal atresia. J Obstet Gynaecol Res. 2012;38(1):215-219.
Zerhouni S, Mayer C, Skarsgard ED. Can we select fetuses with intra-abdominal calcification for delivery in neonatal surgical centres? J Pediatr Surg. 2013;48(5):946-950.
Hollier LM, Leveno KJ, Kelly MA, MCIntire DD, Cunningham FG. Maternal age and malformations in singleton births. Obstet Gynecol. 2000;96(5 Pt 1):701-706.
Baird PA, Sadovnick AD, Yee IM. Maternal age and birth defects: a population study. Lancet. 1991;337(8740):527-530.
Goetzinger KR, Shanks AL, Odibo AO, et al. Advanced maternal age and the risk of major congenital anomalies. Am J Perinatol. 2017;34:217-222.

Auteurs

Ashleigh Laird (A)

School of Clinical Sciences at Monash Health, Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.

Paul Shekleton (P)

Fetal Diagnostic Unit, Monash Health, Melbourne, Victoria, Australia.

Ramesh M Nataraja (RM)

Department of Paediatric Surgery, Monash Children's Hospital, Melbourne, Victoria, Australia.
Department of Paediatrics.
Department of Surgery,School of Clinical Sciences at Monash Health, Medicine, Nursing and Health Sciences, Monash University,, Melbourne, Victoria, Australia.

Christopher Kimber (C)

Department of Paediatric Surgery, Monash Children's Hospital, Melbourne, Victoria, Australia.
Department of Paediatrics.

Maurizio Pacilli (M)

Department of Paediatric Surgery, Monash Children's Hospital, Melbourne, Victoria, Australia.
Department of Paediatrics.
Department of Surgery,School of Clinical Sciences at Monash Health, Medicine, Nursing and Health Sciences, Monash University,, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH